You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海正藥業(600267.SH):台州工廠四個原料藥產品恢復CEP證書
格隆匯 03-18 19:00

格隆匯3月18日丨海正藥業(600267.SH)公佈,近日,公司收到歐洲藥品質量管理局EDQM通知函,決定恢復公司阿卡波糖、伊維菌素、普伐他汀鈉、辛伐他汀四個原料藥歐洲藥典適用性認證證書(簡稱“CEP證書”)。

阿卡波糖主要用於治療2型糖尿病的原料藥。目前國內生產廠商有麗珠集團新北江製藥股份有限公司、石藥集團聖雪葡萄糖有限責任公司等。

伊維菌素主要用於治療抗寄生蟲的原料藥,目前國內只海正藥業持有相關原料藥證書。

普伐他汀鈉主要用於治療高血脂症的原料藥。目前國內生產廠商有上海天偉生物製藥有限公司、廣東藍寶製藥有限公司、麗珠集團新北江製藥股份有限公司等。

辛伐他汀主要用於治療高血脂症的原料藥。目前國內生產廠商有江蘇聯環藥業股份有限公司、魯南貝特製藥有限公司等。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account